Home > Products > CD123 & CD3
> Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (scIgG)
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (scIgG) (CAT#: SCIGG-030)
Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD123 and anti-CD3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myelogenous leukemia (AML); Chronic myelogenous leukemia (CML); Plasmacytoid leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD123 x Anti-CD3 Bispecific Antibody (scIgG) (SCIGG-030). Click the button below to contact us or submit your feedback about this product.